Skip to main content

Thromboembolism after Cardiac Valve Replacement

  • Chapter
Cardiac Valve Replacement

Abstract

The use of two entirely different types of cardiac valve substitutes centers primarily on the continuing debate on the risks of thromboembolism and anticoagulation morbidity associated with prosthetic valves and the long-term durability problems of bioprostheses. After the development of the STARR-EDWARDS® ball valve, which was hemodynamically quite sound, bioprosthetic valves were developed because these valves allegedly did not require anticoagulation, nor did they have a significant incidence of associated thromboembolism. This presentation will try to elucidate some of the mechanisms and causative factors of thromboembolism after valve replacement.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Tepley JF, Grunkemeier GL, Sutherland HD, et al: The ultimate prognosis after valve replacement: An assessment at twenty years. Ann Thorac Surg 1981; 32: 111–119.

    Article  Google Scholar 

  2. Cohn LH, Allred EN, DiSesa VJ, et al: Early and late risk of aortic valve replacement: A 12-year concomitant comparison of the porcine bioprosthetic and tilting disc prosthetic aortic valves. J. Thorac Cardiovasc Surg (in press).

    Google Scholar 

  3. Gajewski J, Singer RB: Mortality in an insured population with atrial fibrillation. JAMA 1981; 245: 1540–1544.

    Article  PubMed  CAS  Google Scholar 

  4. Edmunds LH: Thromboembolic complications of current cardiac valvular prostheses. Ann Thorac Surg 1982; 34: 96–106.

    Article  PubMed  Google Scholar 

  5. Kannel WB, Abbott RD, Savage DD, et al: Epidemiologic features of chronic atrial fibrillation. N Engl J Med 1982; 306: 1018–1021.

    Article  PubMed  CAS  Google Scholar 

  6. Betriu A, Chaitman BR, Almazan A, et al: Preoperative determinants of return to sinus rhythm after valve replacement, in Cohn LH, Gallucci V (eds), Cardiac Bioprostheses, New York, Yorke Medical Books, 1982, pp 184–191.

    Google Scholar 

  7. Nunez L, Gil Aguada M, Celemin D, et al: Aspirin or Coumadin as the drug of choice for valve replacement with porcine bioprosthesis. Ann Thorac Surg 1982; 33: 354–358.

    Article  PubMed  CAS  Google Scholar 

  8. Salazar E, Zajarias A, Gutierrez N, et al: The problem of cardiac valve prostheses, anticoagulants and pregnancy. Circulation 1983; 68 (III): III - 318.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Cohn, L.H. (1985). Thromboembolism after Cardiac Valve Replacement. In: Matloff, J.M. (eds) Cardiac Valve Replacement. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2601-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2601-4_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9629-4

  • Online ISBN: 978-1-4613-2601-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics